A secondary analysis of the AUGUSTUS trial confirms earlier findings that treating heart patients with the anticoagulant apixaban results in less major bleeding, hospitalization and death than warfarin, a standard-of-care blood thinner.
The FDA has approved bempedoic acid as an adjunct to diet and maximally tolerated statin therapy for adults with heterozygous familial hypercholesterolemia.
Members of the nation’s largest association for accountable care organizations have asked CMS to make some suggested changes to the new direct contracting payment models and release additional details. Not doing so could “derail” the new payment reform, according to NAACOS.
A new international partnership is focused on using AI technology to take a closer look at the human brain and advance amyotrophic lateral sclerosis (ALS) research.
The novel coronavirus originating from China has continued to spread around the world and has increased the risk of drug shortages in the U.S. as a result of dependence on Chinese drug ingredients.
The nation’s fourth largest private payer detailed a small list of exceptions, including if a patient is less than age 10 or has a contrast agent allergy.
UnitedHealth Group, which owns the nation’s largest health insurance provider UnitedHealthcare, has parted ways with physician staffing firm Mednax, and cut the company from its in-network providers.
Babies who suffer from a lack of oxygen are often treated using whole-body cooling in order to save brain tissue, but until now it's been difficult to determine how this therapy actually impacts the organ.
